BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22395014)

  • 1. [Methylphenidate induced ST elevation acute myocardial infarction].
    Ruwald MH; Ruwald AC; Tønder N
    Ugeskr Laeger; 2012 Mar; 174(10):647-8. PubMed ID: 22395014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myocardial infarction related to methylphenidate for adult attention deficit disorder.
    Thompson J; Thompson JR
    J Emerg Med; 2010 Jan; 38(1):18-21. PubMed ID: 18024065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous methylphenidate: an unusual way to provoke ST-elevation myocardial infarction.
    Hay E; Shklovski V; Blaer Y; Shlakhover V; Katz A
    Am J Emerg Med; 2015 Feb; 33(2):313.e1-3. PubMed ID: 25200508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate: abuse and addiction.
    Prescrire Int; 2012 Oct; 21(131):241. PubMed ID: 23189380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of acute cardiomyopathy and pericarditis associated with methylphenidate.
    Dadfarmay S; Dixon J
    Cardiovasc Toxicol; 2009 Mar; 9(1):49-52. PubMed ID: 19296063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosis in a cocaine-dependent patient with ADHD during treatment with methylphenidate.
    Delavenne H; Duarte Garcia F; Lacoste J; Cortese S; Charles-Nicolas A; Ballon N
    Gen Hosp Psychiatry; 2013; 35(4):451.e7-9. PubMed ID: 22739113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety of ADHD medications: rationale for and design of an investigator-initiated observational study.
    Hennessy S; Schelleman H; Daniel GW; Bilker WB; Kimmel SE; Guevara J; Cziraky MJ; Strom BL
    Pharmacoepidemiol Drug Saf; 2010 Sep; 19(9):934-41. PubMed ID: 20623519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac arrest with pulseless electrical activity associated with methylphenidate in an adolescent with a normal baseline echocardiogram.
    Daly MW; Custer G; McLeay PD
    Pharmacotherapy; 2008 Nov; 28(11):1408-12. PubMed ID: 18957001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photophobia and methylphenidate.
    Ghanizadeh A; Aghakhani K
    Psychopharmacol Bull; 2008; 41(1):171-3. PubMed ID: 18362880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
    van der Feltz-Cornelis CM; Aldenkamp AP
    Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral vasculitis following oral methylphenidate intake in an adult: a case report.
    Thomalla G; Kucinski T; Weiller C; Röther J
    World J Biol Psychiatry; 2006; 7(1):56-8. PubMed ID: 16428221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of Concerta misuse in a patient with comorbid substance use disorder and attention deficit hyperactivity disorder.
    Rizkallah E; Legault L; Pampoulova T; Lévesque S; Bélanger M; Stavro K; Chiasson JP; Potvin S
    Am J Addict; 2011; 20(5):478-9. PubMed ID: 21838849
    [No Abstract]   [Full Text] [Related]  

  • 20. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H; Lewis J
    Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.